Plasma trimethylamine-N-oxide and related metabolites are associated to type 2 diabetes risk in the PREDIMED trial

Autores: Papandreou, C.; Bullo, M. ; Zheng, Y. ; Ruiz-Canela, Miguel; Yu, E. ; Guasch-Ferre, M.; Toledo Atucha, Estefanía; Clish, C.; Corella, D.; Estruch, R.; Ros, E. ; Fito, M.; Aros, F. ; Fiol, M.; Lapetra, J. ; Serra-Majem, L.; Gomez-Gracia, E. ; Liang, L. ; Fragkiadakis, G. ; Razquin Burillo, Cristina; Hu, F. ; Salas-Salvado, J.